Clinical features of immune checkpoint inhibitor-related cardiotoxicity

被引：0
|
作者：
Kirichenko, Y. Yulia [1 ]
Belenkov, Y. [1 ]
Lyon, A. R. [2 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
[2] Royal Brompton Hosp, London, England
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2165
引用
收藏
页码：564 / 564
页数：1
相关论文
共 50 条
  • [31] Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis
    Izumi, Ryo
    Hashimoto, Toru
    Kisanuki, Hiroshi
    Ikuta, Kei
    Otsuru, Wataru
    Asakawa, Soshun
    Yamamoto, Shoei
    Misumi, Kayo
    Fujino, Takeo
    Shinohara, Keisuke
    Matsushima, Shouji
    Hosokawa, Kazuya
    Katsuki, Shunsuke
    Mori, Taro
    Hashisako, Mikiko
    Tateishi, Yuki
    Iwasaki, Takeshi
    Oda, Yoshinao
    Kinugawa, Shintaro
    Abe, Kohtaro
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [32] Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting
    Moey, Melissa Y. Y.
    Tomdio, Anna N.
    McCallen, Justin D.
    Vaughan, Lauren M.
    O'Brien, Kevin
    Naqash, Abdul R.
    Cherry, Cynthia
    Walker, Paul R.
    Carabello, Blase A.
    JACC: CARDIOONCOLOGY, 2020, 2 (03): : 491 - 502
  • [33] Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis
    Panneerselvam, Kavea
    Amin, Rajan
    Wei, Dongguang
    Tan, Dongfeng
    Lum, Phillip
    Zhang, Hao Chi
    Richards, David
    Altan, Mehmet
    Grivas, Petros
    Thompson, John
    Thomas, Anusha Shirwaikar
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S226 - S227
  • [34] A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis
    Zhou, Lin
    Yang, Shuhui
    Li, Youtao
    Xue, Cheng
    Wan, Renping
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity
    Zarifa, Abdulrazzak
    Lopez-Mattei, Juan
    Palaskas, Nicolas L.
    Iliescu, Cezar
    Durand, Jean-Bernard
    Kim, Peter Y.
    IMMUNOTHERAPY, 4TH EDITION, 2021, 1342 : 377 - 387
  • [36] Rheumatologic immune checkpoint inhibitor-related adverse events
    Defoe, Melissa
    Bermas, Bonnie L.
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (03) : 141 - 148
  • [37] Successful treatment of immune checkpoint inhibitor-related periaortitis
    Buhrer, Elias D.
    Alberts, Ian L.
    Christ, Lisa
    Ozdemir, Berna C.
    SWISS MEDICAL WEEKLY, 2024, 154
  • [38] Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
    Chuzi, Sarah
    Tavora, Fabio
    Cruz, Marcelo
    Costa, Ricardo
    Chae, Young Kwang
    Carneiro, Benedito A.
    Giles, Francis J.
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 207 - 213
  • [39] Immune Checkpoint Inhibitor-Related Myocarditis and Overlapping Syndromes
    Heffernan, Shannon
    Chen, Yimin
    Tehrani, Babak
    Ewer, Steven
    Hillerson, Dustin
    Rahko, Peter S.
    CIRCULATION, 2023, 148
  • [40] Immune checkpoint inhibitor-related risk of pulmonary AEs
    Reactions Weekly, 2024, 1997 (1) : 12 - 12
12345